Treatment and Research

Navigating Difficult-to-Treat IBD: Options, hopes, and next steps Do you live with inflammatory bowel disease (IBD) and feel like you’ve tried everything for your Crohn’s disease or ulcerative colitis? This webinar, “Navigating Difficult-to-Treat IBD: Options, Hopes, and Next Steps,” is designed for patients who feel frustrated, exhausted, or unsure what to do next in their care journey. You’ll hear clear, honest explanations in patient-friendly language, and you’ll come away with questions you can bring to your own doctor and ideas for feeling more in control of your health.

IBD Insider 2026: Patient Updates from the Crohn’s & Colitis Congress® Discover the latest in Crohn’s disease and ulcerative colitis care. You’ll hear directly from patient reporters and expert clinicians as they break down new research and what it could mean for your treatment options. In this webinar: ✅Patient reporters share their personal highlights and takeaways from the Crohn’s & Colitis Congress ✅Intestinal ultrasound for IBD: what it is, how it works, and what patients can expect ✅JAK inhibitors: what they are, when they may be used, and potential benefits and risks ✅Q&A session where panelists answer common questions from patients and caregivers This session is designed to help people living with IBD feel more informed, empowered, and prepared to talk with their care team about current and emerging treatment options.

IBD Medications: How do I choose the right one? When it comes to deciding the right IBD medication there are a lot of factors to consider - your disease type, severity, age, medical history, financial considerations, and much more. As there is no "one size fits all" approach to IBD treatment, it's important to understand all options to find the best fit for you. View our virtual webinar to learn from IBD experts about choosing, starting, and switching medications and how to best address these concerns with your healthcare team.

Biosimilars: What you need to know Learn more about IBD biosimilar medications, understand when and how to switch or start one, and become more knowledgeable about what biosimilar medications are currently approved and available to treat IBD.